(Q34289440)

1 August 2017

1 reference

title

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. (English)

1 reference

1 August 2017

Patricia L Brubaker

1

1 reference

1 August 2017

Younes Anini

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Canadian Journal of Physiology and Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

81

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

1005-1012

1 reference

Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells

1 August 2017

cites work

1 reference

Role of leptin in the regulation of glucagon-like peptide-1 secretion

21 January 2018

1 reference

Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats

21 January 2018

1 reference

Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2

21 January 2018

1 reference

Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse

21 January 2018

1 reference

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans

21 January 2018

1 reference

Regulation of Intestinal Proglucagon- Derived Peptide Secretion by Intestinal Regulatory Peptides*

21 January 2018

1 reference

Structure-Function of the Glucagon Receptor Family of G Protein-Coupled Receptors: The Glucagon, GIP, GLP-1, and GLP-2 Receptors

21 January 2018

1 reference

Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose

21 January 2018

1 reference

Biological actions and therapeutic potential of the glucagon-like peptides

21 January 2018

1 reference

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

21 January 2018

1 reference

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

Therapeutic opportunities from muscarinic receptor research

21 January 2018

1 reference

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

21 January 2018

1 reference

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

21 January 2018

1 reference

A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line

21 January 2018

1 reference

GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.

21 January 2018

1 reference

Duodenal leptin stimulates cholecystokinin secretion: evidence of a positive leptin-cholecystokinin feedback loop

21 January 2018

1 reference

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

21 January 2018

1 reference

Ancient duplications of the human proglucagon gene

21 January 2018

1 reference

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

21 January 2018

1 reference

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

21 January 2018

1 reference

Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2.

21 January 2018

1 reference

Developmental and tissue-specific regulation of proglucagon gene expression.

21 January 2018

1 reference

Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion

21 January 2018

1 reference

Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling

21 January 2018

1 reference

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion

21 January 2018

1 reference

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

Luminal glucagon-like peptide-1(7–36) amide-releasing factors in the isolated vascularly perfused rat colon

21 January 2018

1 reference

Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

21 January 2018

1 reference

Glucose-sensing in glucagon-like peptide-1-secreting cells

21 January 2018

1 reference

A human cellular model for studying the regulation of glucagon-like peptide-1 secretion

21 January 2018

1 reference

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

21 January 2018

1 reference

Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro

21 January 2018

1 reference

Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide

21 January 2018

1 reference

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients

21 January 2018

1 reference

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

21 January 2018

1 reference

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

21 January 2018

1 reference

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

21 January 2018

1 reference

Structure of the human glucagon gene

21 January 2018

1 reference

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

21 January 2018

1 reference

Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat

21 January 2018

1 reference

Ileal release of glucagon-like peptide-1 (GLP-1)

21 January 2018

1 reference

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

21 January 2018

1 reference

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y03-107

1 reference

1 August 2017

1 reference